Biblio
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma. J Clin Oncol. 2024:JCO2302232.
Role of Patient Characteristics and Insurance Type in Newly Diagnosed Multiple Myeloma Care Disparities. JCO Oncol Pract. 2024:OP2300672.
. Advancements and future trends of immunotherapy in light-chain amyloidosis. Crit Rev Oncol Hematol. 2023:103917.
. .
Progress in Research: Daratumumab Improves Treatment Outcomes of Patients with AL Amyloidosis. Crit Rev Oncol Hematol. 2021:103435.
. Outcome of Fludarabine Based Conditioning in High Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single Center Study from Pakistan. Biol Blood Marrow Transplant. 2019.
Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Ph+ ALL, A Systematic Review. Biol Blood Marrow Transplant. 2019.
Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors Before and After Allogeneic transplantation. Biol Blood Marrow Transplant. 2018.
.
Plerixafor as a salvage mobilization strategy for haploidentical peripheral blood allogeneic stem cell transplantation. Clin Case Rep. 2015;3(9):728-30.
.